Pyzchiva 45 mg/0.5 mL
Pyzchiva 45 mg/0.5 mL is a medicine authorised by Swissmedic under authorisation number 69986. The authorisation holder is Samsung Bioepis CH GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 March 2025 and the authorisation is limited until 20 March 2030. ATC code L04AC05 places the medicine in the group Immunosuppressants.
| Authorisation number | 69986 |
|---|---|
| Name | Pyzchiva 45 mg/0.5 mL |
| Full name | Pyzchiva 45 mg/0.5 mL, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Samsung Bioepis CH GmbH |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AC05 |
| First authorisation | 21 March 2025 |
| Authorisation validity | 20 March 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pyzchiva 45 mg/0.5 mL, Injektionslösung in einer Fertigspritze | B | 21 March 2025 |
| 2 | Pyzchiva 90 mg/1 mL, Injektionslösung in einer Fertigspritze | B | 21 March 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | L04AC05 | 07.15.0. | B |
| 2 | 1 | Fertigspritze(n) | L04AC05 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Pyzchiva 45 mg/0.5 mL authorised in Switzerland?
Yes. Pyzchiva 45 mg/0.5 mL is authorised by Swissmedic under authorisation number 69986, data as of 01 September 2026. The authorisation is limited until 20 March 2030.
Which dispensing category does Pyzchiva 45 mg/0.5 mL have?
Pyzchiva 45 mg/0.5 mL is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Pyzchiva 45 mg/0.5 mL?
The authorisation holder is Samsung Bioepis CH GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.